Anderson Glen R. 13D and 13G filings for Indaptus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-08-16 5:57 pm Purchase | 2023-08-14 | 13G | Indaptus Therapeutics, Inc. INDP | Anderson Glen R. | 42,514 14.170% | 3,691 (+9.51%) | Filing |
| 2022-07-07 7:40 pm Purchase | 2022-06-27 | 13G | Indaptus Therapeutics, Inc. INDP | Anderson Glen R. | 38,823 13.160% | 12,463 (+47.28%) | Filing |
| 2021-11-17 09:00 am Purchase | 2021-09-29 | 13D | Indaptus Therapeutics, Inc. INDP | Anderson Glen R. | 26,360 9.000% | 7,495 (+39.73%) | Filing |
| 2021-10-26 5:16 pm Purchase | 2021-09-29 | 13D | Indaptus Therapeutics, Inc. INDP | Anderson Glen R. | 18,866 6.400% | 4,133 (+28.05%) | Filing |
| 2021-08-19 4:05 pm Purchase | 2021-08-03 | 13D | Indaptus Therapeutics, Inc. INDP | Anderson Glen R. | 14,733 7.600% | 14,733 (New Position) | Filing |